HUP0302675A3 - New crystalline modifications of lopinavir - Google Patents

New crystalline modifications of lopinavir

Info

Publication number
HUP0302675A3
HUP0302675A3 HU0302675A HUP0302675A HUP0302675A3 HU P0302675 A3 HUP0302675 A3 HU P0302675A3 HU 0302675 A HU0302675 A HU 0302675A HU P0302675 A HUP0302675 A HU P0302675A HU P0302675 A3 HUP0302675 A3 HU P0302675A3
Authority
HU
Hungary
Prior art keywords
lopinavir
new crystalline
crystalline modifications
modifications
new
Prior art date
Application number
HU0302675A
Other languages
Hungarian (hu)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27065762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0302675(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/793,536 external-priority patent/US6608198B2/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HUP0302675A2 publication Critical patent/HUP0302675A2/en
Publication of HUP0302675A3 publication Critical patent/HUP0302675A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0302675A 2000-03-30 2001-03-21 New crystalline modifications of lopinavir HUP0302675A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53825700A 2000-03-30 2000-03-30
US09/793,536 US6608198B2 (en) 2000-03-30 2001-02-27 Crystalline pharmaceutical
PCT/US2001/009112 WO2001074787A2 (en) 2000-03-30 2001-03-21 Crystalline pharmaceutical

Publications (2)

Publication Number Publication Date
HUP0302675A2 HUP0302675A2 (en) 2003-12-29
HUP0302675A3 true HUP0302675A3 (en) 2004-03-29

Family

ID=27065762

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302675A HUP0302675A3 (en) 2000-03-30 2001-03-21 New crystalline modifications of lopinavir

Country Status (22)

Country Link
EP (1) EP1268442A2 (en)
JP (1) JP2003529592A (en)
KR (1) KR100773258B1 (en)
CN (2) CN1330639C (en)
AR (2) AR033360A1 (en)
AU (3) AU2001250920B2 (en)
BG (1) BG107165A (en)
BR (1) BR0109433A (en)
CA (1) CA2403635A1 (en)
CZ (1) CZ20023529A3 (en)
HU (1) HUP0302675A3 (en)
IL (1) IL151551A0 (en)
MX (1) MXPA02009559A (en)
MY (1) MY128296A (en)
NO (1) NO325005B1 (en)
NZ (1) NZ521183A (en)
PE (1) PE20011232A1 (en)
PL (1) PL359727A1 (en)
SA (2) SA06270303B1 (en)
SK (1) SK14832002A3 (en)
TW (1) TWI284640B (en)
WO (1) WO2001074787A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608198B2 (en) 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
WO2010089753A2 (en) * 2009-02-06 2010-08-12 Hetero Research Foundation Novel polymorphs of lopinavir
WO2011025849A1 (en) * 2009-08-27 2011-03-03 Merck Sharp & Dohme Corp. Processes for preparing protease inhibitors of hepatitis c virus
CN112830899A (en) * 2021-01-18 2021-05-25 合肥华方医药科技有限公司 Novel lopinavir crystal form and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
WO1998057648A1 (en) * 1997-06-16 1998-12-23 Vertex Pharmaceuticals Incorporated Methods of increasing the bioavailability of stable crystal polymorphs of a compound

Also Published As

Publication number Publication date
JP2003529592A (en) 2003-10-07
SA06270303B1 (en) 2009-08-02
TWI284640B (en) 2007-08-01
HUP0302675A2 (en) 2003-12-29
KR100773258B1 (en) 2007-11-05
KR20030011807A (en) 2003-02-11
WO2001074787A2 (en) 2001-10-11
NO20024679D0 (en) 2002-09-30
AU5092001A (en) 2001-10-15
NZ521183A (en) 2004-03-26
AU2001250920B2 (en) 2006-06-29
CN101066952A (en) 2007-11-07
PL359727A1 (en) 2004-09-06
WO2001074787A3 (en) 2002-02-07
NO325005B1 (en) 2008-01-14
AU2006222711A1 (en) 2006-10-19
BR0109433A (en) 2004-08-10
AR049560A2 (en) 2006-08-16
SK14832002A3 (en) 2003-02-04
PE20011232A1 (en) 2001-12-08
MY128296A (en) 2007-01-31
AR033360A1 (en) 2003-12-17
CN1330639C (en) 2007-08-08
CA2403635A1 (en) 2001-10-11
IL151551A0 (en) 2003-04-10
EP1268442A2 (en) 2003-01-02
MXPA02009559A (en) 2003-05-21
SA01220270B1 (en) 2006-11-14
NO20024679L (en) 2002-09-30
CN1422259A (en) 2003-06-04
BG107165A (en) 2003-07-31
CZ20023529A3 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
HK1049954A1 (en) Compound sanitary napkin
IL150934A0 (en) Pyrimidine compounds
AU6425601A (en) Plaster
GB0025782D0 (en) Use of inhibitors
EP1284138A4 (en) Plaster
GB0007307D0 (en) Crystalline form || of cabergoline
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
HUP0302675A3 (en) New crystalline modifications of lopinavir
IL188485A0 (en) New use of iloperidone
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
PL350963A1 (en) Use of arylalkanoylpyridazines
TW422046U (en) Improved structure of spoon
HK1053059A1 (en) New use of imidazotriazinon derivatives
TW424905U (en) Improved structure of drum-beater
HK1045948A1 (en) New crystalline form of omeprazole
TW414007U (en) Structure of water-dripping irrigator
TW459823U (en) Improved structure of washbasin
PL340617A1 (en) Derivatives of 2-acylpyridine
TW461568U (en) Structure improvement of pressing-switch
TW496608U (en) Structure improvement of row-wire fixing-stage
TW415609U (en) Structure improvement of punching-card clock
GB0009043D0 (en) New autitumoural derivatives of ET-743
GB0111083D0 (en) Formation of small crystals
GB0127380D0 (en) Formation of small crystals
TW432952U (en) Improved structure of lunch-box

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees